||As you are aware, from 1 February 2018, medicines containing codeine will no longer be available over the counter in pharmacies.
The Therapeutic Goods Administration (TGA) is working in collaboration with Primary Health Networks and pain specialists to ensure health professionals dealing with chronic and acute pain management have alternative strategies to use in preparation for 1 February and beyond.
TGA have developed a codeine information hub with a wide range of resources for health professionals available.
As part of this work, the TGA have recently hosted a national series of workshops on the up-scheduling of codeine. These sessions provided attendees the opportunity to engage with senior TGA representatives, as well as leading specialists in acute and chronic pain management and addiction.
You can access the presentation from the Brisbane
(13 Dec) sessions on the TGA website.
The event featured presentations from a range of subject matter experts as well as an interesting panel discussion, and we encourage you to access these. Video links
from the Melbourne session are listed below and are also available from the TGA website
- Professor John Skerritt & Avi Rebera – Changes to codeine product access: Background to the decision to change to prescription-only
- Pene Wood – Alternative options to codeine in the pharmacy
- Dr Malcolm Hogg – Rethinking our approach to pain and the role of opioid therapy
- Dr Mathew Frei – Over the counter, down the hatch: OTC codeine use
- Dr Malcolm Hogg – Delivering pain management in a rural setting
- Panel Q&A Session